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Background: Non-adherence with clopidogrel after coronary stenting may be associated with an adverse outcome. We analysed province-wide 
data to establish if non-adherence with clopidogrel was associated with death or MI.
methods: We linked provincial registries to determine clopidogrel use and outcomes for patients receiving a coronary stent in British Columbia 
(2004-2006). Non-adherence was defined as not filling a clopidogrel prescription for 5 or more days in 12 months post drug-eluting stents (DES) or 
1 month post bare-metal stent (BMS). A cox proportional hazard regression model was used to estimate hazard ratios for clopidogrel non-adherence 
on outcomes. Follow-up was 4 years.
results: A total of 15,629 patients received a coronary stent (3,599 DES, 12,030 BMS). Clopidogrel non-adherence within 12 months post-DES 
was associated with increased mortality (HR 1.95; 95%CI 1.47-2.58), MI (HR 1.4; 95% CI 1.1-1.81), and death or MI (HR 1.58; 95%CI 1.29-1.92). 
Clopidogrel non-adherence within 1 month post-BMS was associated with increased mortality (HR 1.66; 95%CI 1.24-2.21), and death or MI (HR 
1.43; 95%CI 1.11-1.85).
conclusions: Non-adherence with clopidogrel after coronary stenting is associated with increased death and MI. This is the largest study to date 
investigating the effect of clopidogrel non-adherence on clinical outcomes. It highlights the need for i) research to understand reasons for non-
adherence, and ii) strategies to improve clopidogrel adherence after coronary stenting.
